$30,000 of MIMEDX lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"regulatory issues related to the delivery of wound management and skin substitutes for Medicare patients"
You can find more data on corporate lobbying on Quiver Quantitative.
MDXG Insider Trading Activity
MDXG insiders have traded $MDXG stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MDXG stock by insiders over the last 6 months:
- KIMBERLY MAERSK-MOLLER (Chief Commercial Officer) sold 58,300 shares for an estimated $432,329
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MDXG Hedge Fund Activity
We have seen 103 institutional investors add shares of MDXG stock to their portfolio, and 105 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST LIGHT ASSET MANAGEMENT, LLC added 1,725,458 shares (+89.5%) to their portfolio in Q3 2025, for an estimated $12,043,696
- NANTAHALA CAPITAL MANAGEMENT, LLC added 1,466,566 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,236,630
- DISCIPLINED GROWTH INVESTORS INC /MN added 1,022,202 shares (+283.0%) to their portfolio in Q3 2025, for an estimated $7,134,969
- TRIGRAN INVESTMENTS, INC. removed 689,430 shares (-8.2%) from their portfolio in Q3 2025, for an estimated $4,812,221
- MILLENNIUM MANAGEMENT LLC removed 534,790 shares (-32.0%) from their portfolio in Q3 2025, for an estimated $3,732,834
- AQR CAPITAL MANAGEMENT LLC added 510,017 shares (+1502.8%) to their portfolio in Q3 2025, for an estimated $3,559,918
- GOLDMAN SACHS GROUP INC added 480,476 shares (+62.7%) to their portfolio in Q3 2025, for an estimated $3,353,722
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MDXG Analyst Ratings
Wall Street analysts have issued reports on $MDXG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 12/17/2025
To track analyst ratings and price targets for MDXG, check out Quiver Quantitative's $MDXG forecast page.
MDXG Price Targets
Multiple analysts have issued price targets for $MDXG recently. We have seen 2 analysts offer price targets for $MDXG in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Brooks O'Neil from Lake Street set a target price of $10.0 on 01/20/2026
- Anthony Petrone from Mizuho set a target price of $10.0 on 12/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
